The Vox Markets Podcast / Richard Hullihen, CEO of Polarean Imaging #POLX talks about why they requested a priority review for their new drug application to the US FDA

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.